Something is happening in the world of nutrition that nobody saw coming. EatingWell reported a 9,500% increase in page views on fiber-related articles in the past year. NPR covered it in May 2026. Johns Hopkins named it a top food trend. The CEO of PepsiCo called it publicly on an earnings call. The CEO of […]
Medically reviewed by Dr. Ajit Kumar, MD (Medicine) | Member, Editorial Board, Medimadad Health Editorial Team Millions of people are taking Ozempic, Wegovy, and Mounjaro with impressive results. But a growing body of research is asking a question that very few people in the weight loss conversation are talking about: why do so many patients […]
🦺Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author | Editorial Policy Everyone knows Ozempic and Wegovy for one reason: weight loss. But in 2026, a wave of new research is revealing something that is catching even doctors off guard. These GLP-1 receptor agonist drugs […]
🦺Medically Written & ReviewedBy Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author | Editorial Policy A new weight loss drug is generating some of the most striking clinical trial results ever seen in the field of obesity medicine. Survodutide — developed by Boehringer Ingelheim and Zealand Pharma — produced […]
🦺Medically Written & ReviewedBy Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author | Editorial Policy By now, you’ve heard of Ozempic, Wegovy, and the GLP-1 drug revolution sweeping the world. In 2026 alone, an estimated 13% of adults in the US have used a GLP-1 medication. But what most […]
